,,iv  #aae? ,,congress  #a/ ,session    
,h4 ,,res4 #fi  ,,9 ,,! ,,h\se ,,(      
,,repres5tatives  ,janu>y #cj1 #bjag,mr4
 ,knight 7= himself1 ,ms4 ,spei]1 ,ms4  
,e%oo1 ,mr4 ,mc,caul1 ,mr4 ,crd5as1 ,mr4
 ,murphy ( ,p5nsylvania1 ,mrs4 ,com/ock1
 ,mrs4 ,d+ell1 ,mr4 ,delaney1 ,ms4      
,br[nley ( ,cali=nia1 & ,mr4 ,soto7     
submitt$ ! foll[+ resolution2 :i* 0     
ref]r$ to ! ,committee on ,en]gy &      
,comm]ce  ,,resolution  ,express+       
support = designation ( ! #ag? day 9    
,may z ,,dipg ,aw>5ess ,day to raise    
aw>5ess & enc\rage ! rese>* into cures =
 diffuse intr9sic pont9e glioma 7,,dipg7
 & p$iatric canc]s 9 g5]al4  ,:]eas     
diffuse intr9sic pont9e glioma 7,,dipg7 
affects #bjj to #djj *ildr5 9 ! ,unit$  
,/ates ea* ye> ) c]ta9 regul>ity2 ,:]eas
 bra9 tumors are ! lead+ cause (        
canc]-relat$ dea? 9 *ildr52 ,:]eas      
,,dipg is ! second mo/ common malignant 
bra9 tumor ( *ildhood2 ,:]eas ,,dipg is 
! lead+ cause ( *ildhood dea? due to    
bra9 tumors2 ,:]eas ! m$ian survival "t 

is only #i mon?s po/ diagnosis )        
treatm5t2 ,:]eas #e-ye> survival is less
 ?an #a p]c5t2 ,:]eas giv5 ! age at     
diagnosis & ! av]age life expectancy1 ! 
numb] ( life ye>s lo/ annually because (
 ,,dipg is approximately #be1jjj ye>s ( 
p]son life lo/ 7calculat$ z ! numb] (   
*ildr5 diagnos$ by av]age ( male &      
female life expectancy f t m$ian age1   
#cjj  #hj  #be1jjj ye>s ( p]son life lo/
 annually72 ,:]eas prognosis has n      
improv$ = *ildr5 ) ,,dipg 9 ov] #dj     
ye>s2 & ,:]eas gov]nm5t fund+ = rese>* =
 p$iatric canc] z a s+ul> designation   
has be5 repres5t$ by less ?an #d p]c5t (
 ! ,national ,canc] ,in/itute budget 9  
any giv5 ye>3 ,n[1 !re=e1 be x  ,t !    
,h\se ( ,repres5tatives-- 7#a7 supports 
! designation ( ,,dipg ,aw>5ess ,day2   
7#b7 enc\rages all p ( ! ,unit$ ,/ates  
to become m in=m$ ab\t diffuse intr9sic 
pont9e glioma 7,,dipg7 p$iatric bra9    
canc]1 & ! curr5t *all5ges to ! m$ical  
rese>* sy/em 9 designat+ suffici5t      
rese>* fund+ = p$iatric canc]s2  7#c7   

supports exp&$ rese>* to bett] und]/&   
,,dipg1 develop effective treatm5ts1 &  
provide compreh5sive c>e = *ildr5 )     
,,dipg & _! families2 &  7#d7 enc\rages 
! ,national ,canc] ,in/itute & o!r      
rese>* fund]s to elevate _! consid]ation
 ( mortality rate ( a type ( canc] z    
well z ! life ye>s lo/ z significant    
factors consid]$ dur+ ! grant           
application process4